Company Search:
Advanced Search
Sponsored Links
Luminex Corporation Company Snapshot
Luminex Corporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Luminex with three other companies in this sector in UNITED STATES : Crispr Therapeutics AG (2019 sales of $289.59 million of which 100% was Biotechnology), GW Pharmaceuticals PLC ($311.33 million of which 100% was Novel Therapeutics), and Radius Health Inc ($173.32 million of which 100% was Drug Manufacturer).

Sales Analysis. Luminex reported sales of $334.64 million for the year ending December of 2019. This represents an increase of 6.0% versus 2018, when the company's sales were $315.82 million. Sales at Luminex have increased during each of the previous five years (and since 2014, sales have increased a total of 47%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Luminex Corporation
  Stock Performance Chart for Luminex Corporation
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 26.91
(Figures in U.S. Dollars)
1 Week 4.7%   13 Weeks 8.7%  
4 Weeks 17.0%   52 Weeks 16.9%  
Luminex Corporation Key Data:
  Ticker: LMNX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 334,638,000
(Year Ending Jan 2020).
Employees: 1,247
  Currency: U.S. Dollars Market Cap: 1,192,795,680
  Fiscal Yr Ends: December Shares Outstanding: 44,325,369
  Share Type: Common Closely Held Shares: 2,317,359
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.